Data / Drug companies / Enalapril maleate
Enalapril maleate: 32 companies and 105 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Enalapril maleate is listed in the FDA National Drug Code Directory by 32 companies, with 105 products in commercial distribution. 94 of the products (89.5%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; solution, and the newest product started marketing on August 26, 2026.
The request: Get every company that lists enalapril maleate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 32
- Products
- 105
- Generic (ANDA) products
- 94 (89.5%)
- Application numbers
- 13
- Routes
- Oral
- Brand names
- Vasotec, Epaned
- openFDA record search
- api.fda.gov
Companies that list enalapril maleate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 10 | tablet | Generic drugs (ANDA) | February 24, 2025 |
| Bryant Ranch Prepack | 10 | tablet | Generic drugs (ANDA) | February 24, 2025 |
| Remedyrepack Inc. | 6 | tablet | Generic drugs (ANDA) | January 15, 2025 |
| Preferred Pharmaceuticals Inc. | 5 | tablet | Generic drugs (ANDA) | July 23, 2026 |
| Amici Pharma, Inc. | 4 | tablet | Generic drugs (ANDA) | October 15, 2025 |
| Bausch Health US LLC | 4 | tablet | New drug applications (NDA) | July 26, 1988 |
| Chartwell RX, LLC | 4 | tablet | Generic drugs (ANDA) | October 1, 2020 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 4 | tablet | Generic drugs (ANDA) | October 1, 2020 |
| Major Pharmaceuticals | 4 | tablet | Generic drugs (ANDA) | August 28, 2025 |
| NorthStar Rx LLC | 4 | tablet | Generic drugs (ANDA) | August 6, 2015 |
| Northwind Health Company, LLC | 4 | tablet | Generic drugs (ANDA) | September 7, 2022 |
| NuCare Pharmaceuticals,Inc. | 4 | tablet | Generic drugs (ANDA) | April 24, 2022 |
| Oceanside Pharmaceuticals | 4 | tablet | Authorized generics (NDA) | July 26, 1988 |
| Rising Pharma Holdings, Inc. | 4 | tablet | Generic drugs (ANDA) | February 24, 2025 |
| ScieGen Pharmaceuticals, Inc. | 4 | tablet | Generic drugs (ANDA) | February 12, 2025 |
| Solco Healthcare US, LLC | 4 | tablet | Generic drugs (ANDA) | July 31, 2022 |
| Sun Pharmaceutical Industries, Inc. | 4 | tablet | Generic drugs (ANDA) | January 23, 2001 |
| Coupler LLC | 3 | tablet | Generic drugs (ANDA) | August 26, 2026 |
| Golden State Medical Supply, Inc. | 3 | tablet | Generic drugs (ANDA) | January 23, 2001 |
| Legacy Pharmaceutical Packaging, LLC | 3 | tablet | Generic drugs (ANDA) | October 1, 2020 |
| PD-Rx Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | July 31, 2022 |
| Aurobindo Pharma Limited | 1 | solution | Generic drugs (ANDA) | January 8, 2024 |
| Azurity Pharmaceuticals, Inc. | 1 | solution | New drug applications (NDA) | October 3, 2016 |
| Bionpharma Inc. | 1 | solution | Generic drugs (ANDA) | August 11, 2021 |
| Bryant Ranch Prepack | 1 | tablet | Generic drugs (ANDA) | January 23, 2001 |
| Camber Pharmaceuticals, Inc. | 1 | solution | Generic drugs (ANDA) | February 14, 2022 |
| Golden State Medical Supply, Inc. | 1 | tablet | Generic drugs (ANDA) | January 23, 2001 |
| NorthStar RxLLC | 1 | solution | Generic drugs (ANDA) | May 1, 2024 |
| Proficient Rx LP | 1 | tablet | Authorized generics (NDA) | December 24, 1985 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | January 23, 2001 |
| St. Mary's Medical Park Pharmacy | 1 | tablet | Generic drugs (ANDA) | October 31, 2022 |
| Wilshire Pharmaceuticals, Inc. | 1 | solution | New drug applications (NDA) | April 8, 2024 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 99 | 94.3% |
| Solution | 6 | 5.7% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 94 | 89.5% |
| New drug applications (NDA) | 6 | 5.7% |
| Authorized generics (NDA) | 5 | 4.8% |
Pharmacologic classes
| Class | Products |
|---|---|
| Angiotensin Converting Enzyme Inhibitor | 105 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.